BIOLASE Management
BIOLDelisted Stock | USD 0.05 0.02 27.46% |
BIOLASE employs about 157 people. The company is managed by 7 executives with a total tenure of roughly 14 years, averaging almost 2.0 years of service per executive, having 22.43 employees per reported executive. Inspection of BIOLASE's management performance can provide insight into the company performance.
Matthew Wilson President Vice President of Human Resources |
John Beaver President CFO, Senior Vice President |
BIOLASE |
BIOLASE Management Team Effectiveness
The company has return on total asset (ROA) of (0.2682) % which means that it has lost $0.2682 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.0476) %, meaning that it created substantial loss on money invested by shareholders. BIOLASE's management efficiency ratios could be used to measure how well BIOLASE manages its routine affairs as well as how well it operates its assets and liabilities.BIOLASE Workforce Comparison
BIOLASE is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 14,572. BIOLASE claims roughly 157 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of (0.44) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.45) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.45. BIOLASE Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BIOLASE insiders, such as employees or executives, is commonly permitted as long as it does not rely on BIOLASE's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, BIOLASE insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Lanman Richard B. over six months ago Acquisition by Lanman Richard B. of 138000 shares of BIOLASE subject to Rule 16b-3 | ||
Schuler Education Foundation over six months ago Acquisition by Schuler Education Foundation of 3745000 shares of BIOLASE at 0.4 subject to Rule 16b-3 | ||
Jonathan Lord over six months ago Disposition of 1395 shares by Jonathan Lord of BIOLASE subject to Rule 16b-3 | ||
Schuler Jack W over six months ago Purchase by Schuler Jack W of 8002 shares of BIOLASE | ||
Somerman Martha J Dds Phd over a year ago Acquisition by Somerman Martha J Dds Phd of 518429 shares of BIOLASE subject to Rule 16b-3 |
BIOLASE Notable Stakeholders
A BIOLASE stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BIOLASE often face trade-offs trying to please all of them. BIOLASE's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BIOLASE's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Matthew Wilson | Vice President of Human Resources | Profile | |
John Beaver | CFO, Senior Vice President | Profile | |
David Rodriguez | Director Events | Profile | |
Jennifer Bright | Chief Officer | Profile | |
Russell DDS | Chief Officer | Profile | |
Michael Carroll | Corporate Secretary | Profile | |
Steven Sandor | Chief Officer | Profile |
About BIOLASE Management Performance
The success or failure of an entity such as BIOLASE often depends on how effective the management is. BIOLASE management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BIOLASE management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BIOLASE management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California. Biolase operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 158 people.
BIOLASE Workforce Analysis
Traditionally, organizations such as BIOLASE use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BIOLASE within its industry.BIOLASE Manpower Efficiency
Return on BIOLASE Manpower
Revenue Per Employee | 313.1K | |
Revenue Per Executive | 7M | |
Net Loss Per Employee | 131.4K | |
Net Loss Per Executive | 2.9M | |
Working Capital Per Employee | 33.1K | |
Working Capital Per Executive | 742.9K |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in BIOLASE Stock
If you are still planning to invest in BIOLASE check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the BIOLASE's history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |